Hussman Strategic Advisors’s Concentrix CNXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.02M Buy
147,000
+63,000
+75% +$2.24M 0.87% 7
2025
Q4
$3.49M Buy
84,000
+42,000
+100% +$1.7M 0.84% 11
2025
Q3
$1.94M Buy
+42,000
New +$2.24M 0.42% 106
2025
Q2
Sell
-63,000
Closed -$3.51M 233
2025
Q1
$3.51M Buy
+63,000
New +$3.02M 0.85% 18
2022
Q3
Sell
-13,000
Closed -$1.76M 316
2022
Q2
$1.76M Buy
13,000
+7,800
+150% +$1.17M 0.3% 122
2022
Q1
$866K Hold
5,200
0.17% 195
2021
Q4
$929K Buy
+5,200
New +$928K 0.2% 158

Other funds holding CNXC

Hussman Strategic Advisors's CNXC Position: Q1 2026 in Review

Hussman Strategic Advisors increased its Concentrix (CNXC) stake by 75% in Q1 2026, buying an estimated $2.24M and bringing the position to 147,000 shares worth $4.02M. The position accounts for 0.87% of the portfolio, ranked #7.

Hussman Strategic Advisors first reported a position in CNXC in Q4 2021 and has held it in 7 quarters since. 300 funds tracked by Wall St. Rank hold CNXC as of Q1 2026.

  • Hussman Strategic Advisors held 147,000 shares of Concentrix worth $4.02M as of Q1 2026.
  • Hussman Strategic Advisors bought 63,000 Concentrix shares in Q1 2026, an estimated $2.24M.
  • Concentrix made up 0.87% of Hussman Strategic Advisors's portfolio in Q1 2026, its #7 holding.
  • Hussman Strategic Advisors first reported a position in Concentrix in Q4 2021 and has held it in 7 quarters since.
  • 300 funds tracked by Wall St. Rank held Concentrix as of Q1 2026.

Based on Hussman Strategic Advisors's 13F filing for Q1 2026, filed 11 May 2026.